Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma
Article in Cancer and Metastasis Reviews (February 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Cancer and Metastasis Reviews (February 2024)
Article in European Journal of Cell Biology (January 2023)